Varius Dannenberg

[Varius Dannenberg @Variusdbg]

Case of a massiv TR, solved with 2 anteroseptal XTR Clips. Very happy with only trace residual TR :) #echofirst #CVimaging @ValveDisease @krychtiukmd @cardiovienna @CHengstenbergMD @pe_bartko @ggoliasch @a_kammerlander @MdNitsche @m_koschutnik @g_heitzinger

[kazi ferdous @fazalabul]

Guess the thickness of the walls?

[The Echo Lady @The_echo_lady]

Can you name the defect here? 🍀

#Echofirst #Echocardiography

[Elad Maor @maor_elad]

RV perforation is a concern during tricuspid interventions. In this case we increased patient safety by placing the super stiff wire in the pulmonary artery and not in the apex (SAPIEN S3 29 in Hancock 31). @AmitSegev8 @PCRonline @EleidMack @PhilippLurz @m_taramasso #TAVR

[Varius Dannenberg @Variusdbg]

Excellent result of a mitral valve-in-valve procedure! @ValveDisease @krychtiukmd @cardiovienna @CHengstenbergMD @pe_bartko @ggoliasch @a_kammerlander @MdNitsche @m_koschutnik @g_heitzinger

[PCRonline 🫀 @PCRonline]

Live interactive #cardioed continues even post-#EuroPCR with the 3rd free webinar in the series on transcatheter management of mitral and TR!

Join us for "How to use #TMVR to treat patients with mitral regurgitation" on Wed 2 June 5pm Paris 🕔

https://t.co/QKKnUv6fPh

[SABOURETCardiologist @SABOURETCardio]

I write a little bit better but great quote , agree ? 🤔 @DavidWienerMD @NMerke @DrDerekConnolly @ajaykirtane @dr_benoy_n_shah @mmamas1973 @rahatheart1 @DrMarthaGulati @Sema_Guneri @MeralKayikcoglu @GiuseppeGalati_ @iamritu @YaneValdezT @fitmslax @AnaCatarinaOrt @angioplastyorg

[Eduardo Infante de Oliveira @EIdeOliveiraMD]

The tricuspid team! Full afternoon exchanging great tips and tricks! EuroPCR@Lisbon - second day! #EuroPCR #EuroPCR2021 @APIC_pt @spcardio @GGStefanini @ruict3 @EAPCIPresident @RitaCal3 @PAGoncalves_ @brmelica @CarlosGalvoBra1 @JoanaDelgadoSi1 #YoungEAPCI

[Luis Ortega Paz @Ortega_Paz]

#EuroPCR Today PCR Tricuspid Focus Group was introduced. The Focus Group is committed to fostering the establishment of tricuspid therapies, improving outcomes & delivering sustainable clinical. https://t.co/WtMuQ7RRIS @PCRonline #treatTR #fixTR #PCRtricuspid

[Univ.-Prof. Dr. Ralph Stephan von Bardeleben @vonBardelebenRS]

@hahn_rt @ACCinTouch @escardio @PhilippLurz @azeemlatib @HeartValveCntr @m_taramasso Totally agree, TRIsCEND II has German BfArM approval

[Philipp E. Bartko @pe_bartko]

Socioeconomic Gradients in Mortality Following HF Hospitalization in a Country With Universal Health Care Coverage https://t.co/3RDUx1Ogrw

[European Society of Cardiology @escardio]

Ready for the new #ESCCardioTalk episode?😀

Secondary tricuspid regurgitation: neglected no more! @pe_bartko , @g_heitzinger and @ggoliasch discuss the use of quantitative echocardiography parameters to grade TR https://t.co/0GcizDeBMD

@ehj_ed #EHJ #cardiotwitter #MedTwitter

[Denisa Muraru @denisamuraru]

#3Decho allowing to quantify the regurgitant fraction might improve the way we will assess the FTR severity in future trials and in clinical practice.
Very nice podcast putting our study in perspective by @pe_bartko @g_heitzinger @ggoliasch. Congratulations & thank you! #EHJCVI

[Kardiologie MedUni Wien Forschung @KardiologieWien]

Secondary tricuspid regurgitation? Neglected no more!

@pe_bartko, @ggoliasch and @g_heitzinger from @KardiologieWien @ValveDisease discuss this important topic in the newest @escardio #ESCCardioTalk

- Congratulations!

https://t.co/FCjfYXNeYT

[Structural Heart Vienna @ValveDisease]

#Valve-in-Ring - a valuable tool for recurrent #tricuspid regurgitation due to #annuloplasty failure!
#ViR #vhdTR #tricuspidregurgitation
@ggoliasch @pe_bartko @ValveDisease @MaxPaulWinter @CHengstenbergMD @Variusdbg @m_koschutnik

[Kardiologie MedUni Wien Forschung @KardiologieWien]

Transcatheter treatment by valve-in-valve and valve-in-ring implantation for prosthetic tricuspid valve dysfunction

- an educational review by our @ValveDisease group

https://t.co/ZIATU47uvN